Skip to main content
. 2006 Jun 19;148(8):1051–1059. doi: 10.1038/sj.bjp.0706816

Table 2.

Summary of binding studies using [125I]-VPAC2 agonist

  VPAC2 VPAC1/2 VPAC1+VPAC2
  Ki (nM) Ki (nM) Ki (nM)
VIP 5.3±0.3 6.8±0.5 5.7±0.4
VPAC1 agonist 95±10 101±18 150±20
VPAC2 agonist 3.1±0.3 3.3±0.4 3.8±0.4

Results represent the means±s.e.m. of three independent experiments in duplicate.